|
The funding aligns with the in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody acquired from DartsBio Pharmaceuticals.
|
 |
|
The collaboration integrates Demeetra’s CleanCut CHO platforms and cell line services with NorthX Biologics’ GMP manufacturing expertise.
|
|
|
The aim of the pathway is to remove red tape for bespoke therapies designed for patients with rare diseases.
|
|
|
This deal adds two more siRNA candidates to GSK’s pipeline, which the company is looking to expand as it looks to offset the impacts of key patent expiries within its portfolio.
|
|
|
The submission includes data indicating a meaningful survival benefit for infantile-onset NPC patients treated with adrabetadex.
|
|
